Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)
Ginkgo Bioworks Holdings (DNA) reported Change in Inventory of -$694000.0 for Q2 2023, down 16.64% on a YoY basis from -$832520.2 in Q2 2022, and up 62.59% quarter-over-quarter from -$1.9 million in Q1 2023.
Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings has reported Change in Inventory for 4 years, with the latest figure at -$694000.0 in Q2 2023.
- For the quarter ending Q2 2023, Change in Inventory fell 16.64% year-over-year to -$694000.0; the trailing twelve-month figure through Jun 2023 stood at -$7.5 million (down 238.38% YoY), and the FY2022 full-year result was -$164000.0, down 126.2% from the prior year.
- Change in Inventory for Q2 2023 stood at -$694000.0, up from -$1.9 million in the prior quarter.
- The five-year high for Change in Inventory was $5.3 million in Q1 2022, with the low at -$2.7 million in Q4 2022.
- Historically, Change in Inventory has averaged -$15454.5 across 4 years, with a median of -$595000.0 in 2022.
- The largest YoY upside for Change in Inventory was 683.41% in 2022 against a maximum downside of 2276.79% in 2022.
- Ginkgo Bioworks Holdings' Change in Inventory stood at $1.9 million in 2020, then tumbled by 105.84% to -$112000.0 in 2021, then slumped by 2276.79% to -$2.7 million in 2022, then jumped by 73.93% to -$694000.0 in 2023.
- The last three Change in Inventory figures came in at -$694000.0 (Q2 2023), -$1.9 million (Q1 2023), and -$2.7 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 546.79 Mn | 546.79 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -694,000.00 |
| Jun 30, 2023 | -694,000.00 |
| Mar 31, 2023 | -1.86 Mn |
| Mar 31, 2023 | -1.86 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -595,000.00 |
| Jun 30, 2022 | -595,000.00 |
| Mar 31, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | -112,000.00 |
| Dec 31, 2021 | -112,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Mar 31, 2021 | 681,000.00 |
| Mar 31, 2021 | 681,000.00 |